NCT01502813View on ClinicalTrials.gov

Citicoline, Creatine, and Omega-3 Effects in Middle Age Women

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 1, 2012

Primary Completion Date

October 30, 2018

Study Completion Date

November 1, 2019

Conditions
Cognitive Benefits
Interventions
DRUG

Citicoline, Omega-3 Fatty Acids and Creatine

Citicoline: 500 mg/day for 28 days Omega-3 Fatty Acids: 2 g/day for 28 days Creatine: 5 g/day for 28 days

Trial Locations (1)

84108

The Brain Institute, Salt Lake City

All Listed Sponsors
lead

Deborah Yurgelun-Todd

OTHER

NCT01502813 - Citicoline, Creatine, and Omega-3 Effects in Middle Age Women | Biotech Hunter | Biotech Hunter